The Role of the MAPK Signaling, Topoisomerase and Dietary Bioactives in Controlling Cancer Incidence (original) (raw)
Related papers
Topoisomerase 2 Alpha and the Case for Individualized Breast Cancer Therapy
Annals of Surgical Oncology, 2010
Diagnostic Pathology, 2013
MAPK inhibition by 1α,25(OH)2–Vitamin D3 in breast cancer cells
The Journal of Steroid Biochemistry and Molecular Biology, 2004
Modulation of Sensitivity to Antitumor Agents by Targeting the MAPK Survival Pathway
Current Pharmaceutical Design, 2012
Cancer Research, 2013
Clinical Cancer Research, 2009
Hybrid topoisomerase I and HDAC inhibitors as dual action anticancer agents
PLOS ONE, 2018
2008
medRxiv (Cold Spring Harbor Laboratory), 2024
Clinical Cancer Research, 2006
A Phase II Clinical Trial of Topotecan in Japanese Patients with Relapsed Ovarian Carcinoma
Japanese Journal of Clinical Oncology, 2010
Topoisomerase I is differently phosphorylated in two sublines of L5178Y mouse lymphoma cells
Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression, 1995
Exploring DNA Topoisomerase I Ligand Space in Search of Novel Anticancer Agents
PLoS ONE, 2011
Phytochemicals and cancer chemoprevention
Journal of Cancer Metastasis and Treatment
Journal of Cancer Metastasis and Treatment, 2020
Cancer Prevention: Lessons Learned and Future Directions
Trends in Cancer, 2016
The Mitogen-Activated Protein Kinase Kinase 4 Has a Pro-Oncogenic Role in Skin Cancer
Cancer Research, 2010
Diet and Cancer Prevention: Where We Are, Where We Are Going
Carlos Hernando Murcia Gonzalez
Nutrition and Cancer, 2006
Biomedicine & Pharmacotherapy, 1992
Cancer Preventive and Therapeutic Compounds: Gift From Mother Nature
Cancer Preventive and Therapeutic Compounds: Gift From Mother Nature, 2017
Molecular Cancer Research, 2020
Enhancement of DNA topoisomerase I inhibitor-induced apoptosis by ursodeoxycholic acid
Molecular Cancer Therapeutics, 2006
Recent progress in cancer therapeutics
Translational oncology, 2009
Recent Progress in Cancer Research
Association of Schools of Public Health, 1953
Cutting Edge Therapies for Cancer in the 21st Century
2014
Adenylate Kinase and Metabolic Signaling in Cancer Cells
Frontiers in Oncology, 2020
Tracking the cell cycle origins for escape from topotecan action by breast cancer cells
British Journal of Cancer
Cancer research: On the offensive
Nature, 2002
Toxicology Letters, 2013
Inhibition of G-protein-mediated MAP kinase activation by a new mammalian gene family
Nature, 1996
Pathways connecting inflammation and cancer
Current Opinion in Genetics & Development, 2008
Does bulk damage to DNA explain the cytostatic and cytotoxic effects of topoisomerase II inhibitors?
Biochemical Pharmacology, 1991
Mitotic Arrest Induced by a Novel Family of DNA Topoisomerase II Inhibitors
Journal of Medicinal Chemistry, 2010
Cellular Signalling, 2018
Application of Novel Molecular Biology in Cancer Therapy
Basic & Clinical Cancer Research, 2022
Adem Keski̇n, Journal of Clinical Practice and Research
Journal of Clinical Practice and Research, 2023